How non-drug interventions affect the quality of life of patients suffering from progressive cognitive decline and their main caregiver
Author(s) -
Benedetta LeidiMaimone,
Marie-Laure Notter-Bielser,
Marie-Hélène Laouadi,
Sarah Perrin,
Hélène Métraux,
Daniel Damian,
Camille F. Chavan,
Mélanie Nsir,
Gwendoline Cibelli,
Marie-Jo Tâche,
MarieLouise Montandon,
Joseph Ghika,
JeanFrançois Démonet,
AnneVéronique Dürst,
Andrea Brioschi Guevara
Publication year - 2020
Publication title -
aging
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.473
H-Index - 90
ISSN - 1945-4589
DOI - 10.18632/aging.103291
Subject(s) - psychological intervention , anxiety , quality of life (healthcare) , medicine , dementia , depression (economics) , cognition , affect (linguistics) , cognitive decline , clinical psychology , effects of sleep deprivation on cognitive performance , gerontology , psychiatry , physical therapy , psychology , disease , communication , nursing , economics , macroeconomics
In the absence of cure for age-related neurodegenerative diseases, non-drug interventions (NDIs) represent useful options. Quality of life (QOL) is a multidimensional concept progressively affected by cognitive decline. How single or multiple NDIs impact QOL is unknown.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom